Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lechner-Scott

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 24, 2003
Can the Expanded Disability Status Scale be assessed by telephone?J Lechner-Scott, L Kappos, M Hofman, et al.
European Journal of Neurology|January 20, 2016
Risk of early relapse following the switch from injectables to oral agents for multiple sclerosisT Spelman, L Mekhael, T Burke, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 15, 2024
Onboarding of siponimod in secondary progressive multiple sclerosis patients in Australia: Novel, real-world evidence from the MSGo digital support programmeT A Hardy, P Aouad, M H Barnett, et al.
European Journal of Neurology|March 27, 2015
BREMSO: a simple score to predict early the natural course of multiple sclerosisR Bergamaschi, C Montomoli, G Mallucci, et al.
European Journal of Neurology|October 10, 2018
Anti-inflammatory disease-modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort studyJ Lorscheider, J Kuhle, G Izquierdo, et al.
The Pharmacogenomics Journal|March 23, 2016
Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association studyS Mahurkar, M Moldovan, V Suppiah, et al.
Journal of Neuroimmunology|September 6, 2011
IL28B polymorphisms are not associated with the response to interferon-β in multiple sclerosisS Malhotra, C Morcillo-Suárez, D Brassat, et al.
Genes and Immunity|June 25, 2010
A non-synonymous SNP within membrane metalloendopeptidase-like 1 (MMEL1) is associated with multiple sclerosisM Ban, J L McCauley, R Zuvich, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 22, 2011
The frequency of CSF oligoclonal banding in multiple sclerosis increases with latitudeJ Lechner-Scott, B Spencer, T de Malmanche, et al.
Acta Neurologica Scandinavica|September 14, 2012
Fluctuations of MS births and UV-light exposureF Verheul, J Smolders, M Trojano, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 24, 2003
Can the Expanded Disability Status Scale be assessed by telephone?J Lechner-Scott, L Kappos, M Hofman, et al.
European Journal of Neurology|January 20, 2016
Risk of early relapse following the switch from injectables to oral agents for multiple sclerosisT Spelman, L Mekhael, T Burke, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 15, 2024
Onboarding of siponimod in secondary progressive multiple sclerosis patients in Australia: Novel, real-world evidence from the MSGo digital support programmeT A Hardy, P Aouad, M H Barnett, et al.
European Journal of Neurology|March 27, 2015
BREMSO: a simple score to predict early the natural course of multiple sclerosisR Bergamaschi, C Montomoli, G Mallucci, et al.
European Journal of Neurology|October 10, 2018
Anti-inflammatory disease-modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort studyJ Lorscheider, J Kuhle, G Izquierdo, et al.
The Pharmacogenomics Journal|March 23, 2016
Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association studyS Mahurkar, M Moldovan, V Suppiah, et al.
Journal of Neuroimmunology|September 6, 2011
IL28B polymorphisms are not associated with the response to interferon-β in multiple sclerosisS Malhotra, C Morcillo-Suárez, D Brassat, et al.
Genes and Immunity|June 25, 2010
A non-synonymous SNP within membrane metalloendopeptidase-like 1 (MMEL1) is associated with multiple sclerosisM Ban, J L McCauley, R Zuvich, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 22, 2011
The frequency of CSF oligoclonal banding in multiple sclerosis increases with latitudeJ Lechner-Scott, B Spencer, T de Malmanche, et al.
Acta Neurologica Scandinavica|September 14, 2012
Fluctuations of MS births and UV-light exposureF Verheul, J Smolders, M Trojano, et al.
Pageof 5